{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:41:33Z","timestamp":1772134893138,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K15528"],"award-info":[{"award-number":["JP21K15528"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K08833"],"award-info":[{"award-number":["JP19K08833"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03615"],"award-info":[{"award-number":["JP19H03615"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Philadelphia (Ph) chromosome was the first translocation identified in leukemia. It is supposed to be generated by aberrant ligation between two DNA double-strand breaks (DSBs) at the\n                    <jats:italic>BCR<\/jats:italic>\n                    gene located on chromosome 9q34 and the\n                    <jats:italic>ABL1<\/jats:italic>\n                    gene located on chromosome 22q11. Thus, mimicking the initiation process of translocation, we induced CRISPR\/Cas9-mediated DSBs simultaneously at the breakpoints of the\n                    <jats:italic>BCR<\/jats:italic>\n                    and\n                    <jats:italic>ABL1<\/jats:italic>\n                    genes in a granulocyte-macrophage colony-stimulating factor (GM-CSF) dependent human leukemia cell line. After transfection of two single guide RNAs (sgRNAs) targeting intron 13 of the\n                    <jats:italic>BCR<\/jats:italic>\n                    gene and intron 1 of the\n                    <jats:italic>ABL1<\/jats:italic>\n                    gene, a factor-independent subline was obtained. In the subline, p210\n                    <jats:italic>BCR::ABL1<\/jats:italic>\n                    and its reciprocal\n                    <jats:italic>ABL1::BCR<\/jats:italic>\n                    fusions were generated as a result of balanced translocation corresponding to the Ph chromosome. Another set of sgRNAs targeting intron 1 of the\n                    <jats:italic>BCR<\/jats:italic>\n                    gene and intron 1 of the\n                    <jats:italic>ABL1<\/jats:italic>\n                    gene induced a factor-independent subline expressing p190\n                    <jats:italic>BCR::ABL1<\/jats:italic>\n                    . Both p210 and p190 BCR::ABL1 induced factor-independent growth by constitutively activating intracellular signaling pathways for transcriptional regulation of cell cycle progression and cell survival that are usually regulated by GM-CSF. These observations suggested that simultaneous DSBs at the\n                    <jats:italic>BCR<\/jats:italic>\n                    and\n                    <jats:italic>ABL1<\/jats:italic>\n                    gene breakpoints are initiation events for oncogenesis in Ph+ leukemia. (200\/200 words).\n                  <\/jats:p>","DOI":"10.1038\/s41417-022-00522-w","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T07:02:59Z","timestamp":1661238179000},"page":"38-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Creation of Philadelphia chromosome by CRISPR\/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-4582","authenticated-orcid":false,"given":"Minori","family":"Tamai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thao T. T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kamimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Omachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-6739","authenticated-orcid":false,"given":"Daisuke","family":"Harama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-8111","authenticated-orcid":false,"given":"Atsushi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Goi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-6004","authenticated-orcid":false,"given":"Kazuhito","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-9610","authenticated-orcid":false,"given":"Tadashi","family":"Kaname","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0941-271X","authenticated-orcid":false,"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"522_CR1","first-page":"1497","volume":"132","author":"PC Nowell","year":"1960","unstructured":"Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497\u20139.","journal-title":"Science"},{"key":"522_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290\u20133.","journal-title":"Nature"},{"key":"522_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0308-2261(21)00164-8","volume":"9","author":"JD Rowley","year":"1980","unstructured":"Rowley JD. Ph1-positive leukaemia, including chronic myelogenous leukaemia. Clin Haematol. 1980;9:55\u201386.","journal-title":"Clin Haematol"},{"key":"522_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/306239a0","volume":"306","author":"N Heisterkamp","year":"1983","unstructured":"Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR, et al. Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature. 1983;306:239\u201342.","journal-title":"Nature"},{"key":"522_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36:93\u20139.","journal-title":"Cell"},{"key":"522_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y Ben-Neriah","year":"1986","unstructured":"Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene. Science. 1986;233:212\u20134.","journal-title":"Science"},{"key":"522_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.3541203","volume":"235","author":"SS Clark","year":"1987","unstructured":"Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science. 1987;235:85\u20138.","journal-title":"Science"},{"key":"522_CR8","first-page":"1785","volume":"11","author":"AJ Muller","year":"1991","unstructured":"Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR, et al. BCR first exon sequences specifically activate the BCR\/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol. 1991;11:1785\u201392.","journal-title":"Mol Cell Biol"},{"key":"522_CR9","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","volume":"271","author":"RL Ilaria Jr","year":"1996","unstructured":"Ilaria RL Jr, Van Etten RA. P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem. 1996;271:31704\u201310.","journal-title":"J Biol Chem"},{"key":"522_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","volume":"86","author":"T Skorski","year":"1995","unstructured":"Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, et al. Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood. 1995;86:726\u201336.","journal-title":"Blood"},{"key":"522_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.181.1.307","volume":"181","author":"CL Sawyers","year":"1995","unstructured":"Sawyers CL, McLaughlin J, Witte ON. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med. 1995;181:307\u201313.","journal-title":"J Exp Med"},{"key":"522_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0092-8674(92)90241-4","volume":"70","author":"CL Sawyers","year":"1992","unstructured":"Sawyers CL, Callahan W, Witte ON. Dominant negative MYC blocks transformation by ABL oncogenes. Cell. 1992;70:901\u201310.","journal-title":"Cell"},{"key":"522_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2:561\u20136.","journal-title":"Nat Med"},{"key":"522_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med. 2001;344:1038\u201342.","journal-title":"N Engl J Med"},{"key":"522_CR15","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","volume":"362","author":"H Kantarjian","year":"2010","unstructured":"Kantarjian H, Shah NP, Hochhaus A, Cortes J, Shah S, Ayala M, et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2010;362:2260\u201370.","journal-title":"N Engl J Med"},{"key":"522_CR16","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.1182\/blood-2011-05-351403","volume":"118","author":"R Foa","year":"2011","unstructured":"Foa R, Vitale A, Vignetti M, Meloni G, Guarini A, De Propris MS, et al. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2011;118:6521\u20138.","journal-title":"Blood"},{"key":"522_CR17","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","volume":"362","author":"G Saglio","year":"2010","unstructured":"Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med. 2010;362:2251\u20139.","journal-title":"N Engl J Med"},{"key":"522_CR18","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa055104","volume":"354","author":"H Kantarjian","year":"2006","unstructured":"Kantarjian H, Giles F, Wunderle L, Bhalla K, O\u2019Brien S, Wassmann B, et al. Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. N Engl J Med. 2006;354:2542\u201351.","journal-title":"N Engl J Med"},{"key":"522_CR19","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1056\/NEJMoa1205127","volume":"367","author":"JE Cortes","year":"2012","unstructured":"Cortes JE, Kantarjian H, Shah NP, Bixby D, Mauro MJ, Flinn I, et al. Ponatinib in refractory Philadelphia chromosome-positive leukemias. N. Engl J Med. 2012;367:2075\u201388.","journal-title":"N. Engl J Med"},{"key":"522_CR20","doi-asserted-by":"publisher","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","volume":"85","author":"GQ Daley","year":"1988","unstructured":"Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein. Proc Natl Acad Sci USA. 1988;85:9312\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"522_CR21","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1182\/blood-2004-05-1851","volume":"104","author":"T O\u2019Hare","year":"2004","unstructured":"O\u2019Hare T, Pollock R, Stoffregen EP, Keats JA, Abdullah OM, Moseson EM, et al. Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. Blood. 2004;104:2532\u20139.","journal-title":"Blood"},{"key":"522_CR22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science. 1990;247:824\u201330.","journal-title":"Science"},{"key":"522_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/sj.leu.2403650","volume":"19","author":"Y Chalandon","year":"2005","unstructured":"Chalandon Y, Jiang X, Christ O, Loutet S, Thanopoulou E, Eaves A, et al. BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia. 2005;19:442\u20138.","journal-title":"Leukemia"},{"key":"522_CR24","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","volume":"116","author":"A Rizo","year":"2010","unstructured":"Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R, et al. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34\u2009+\u2009cells. Blood. 2010;116:4621\u201330.","journal-title":"Blood"},{"key":"522_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/344251a0","volume":"344","author":"N Heisterkamp","year":"1990","unstructured":"Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J. Acute leukaemia in bcr\/abl transgenic mice. Nature. 1990;344:251\u20133.","journal-title":"Nature"},{"key":"522_CR26","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1182\/blood.V86.12.4603.bloodjournal86124603","volume":"86","author":"JW Voncken","year":"1995","unstructured":"Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N. BCR\/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood. 1995;86:4603\u201311.","journal-title":"Blood"},{"key":"522_CR27","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1038\/sj.onc.1204638","volume":"20","author":"S Wong","year":"2001","unstructured":"Wong S, Witte ON. Modeling Philadelphia chromosome positive leukemias. Oncogene. 2001;20:5644\u201359.","journal-title":"Oncogene"},{"key":"522_CR28","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1182\/blood.V90.6.2168","volume":"90","author":"A Castellanos","year":"1997","unstructured":"Castellanos A, Pintado B, Weruaga E, Arevalo R, Lopez A, Orfao A, et al. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood. 1997;90:2168\u201374.","journal-title":"Blood"},{"key":"522_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.celrep.2013.08.037","volume":"5","author":"SB Foley","year":"2013","unstructured":"Foley SB, Hildenbrand ZL, Soyombo AA, Magee JA, Wu Y, Oravecz-Wilson KI, et al. Expression of BCR\/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia. Cell Rep. 2013;5:51\u201360.","journal-title":"Cell Rep."},{"key":"522_CR30","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1155390","volume":"320","author":"R Sandberg","year":"2008","unstructured":"Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. Proliferating cells express mRNAs with shortened 3\u2019 untranslated regions and fewer microRNA target sites. Science. 2008;320:1643\u20137.","journal-title":"Science"},{"key":"522_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cell.2009.06.016","volume":"138","author":"C Mayr","year":"2009","unstructured":"Mayr C, Bartel DP. Widespread shortening of 3\u2019UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell. 2009;138:673\u201384.","journal-title":"Cell"},{"key":"522_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","volume":"13","author":"MJ Bueno","year":"2008","unstructured":"Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 2008;13:496\u2013506.","journal-title":"Cancer Cell"},{"key":"522_CR33","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1158\/1535-7163.MCT-08-0482","volume":"7","author":"TS Lee","year":"2008","unstructured":"Lee TS, Ma W, Zhang X, Giles F, Cortes J, Kantarjian H, et al. BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations. Mol Cancer Ther. 2008;7:3834\u201341.","journal-title":"Mol Cancer Ther"},{"key":"522_CR34","doi-asserted-by":"publisher","first-page":"e7661","DOI":"10.1371\/journal.pone.0007661","volume":"4","author":"X Zheng","year":"2009","unstructured":"Zheng X, Oancea C, Henschler R, Moore MA, Ruthardt M. Reciprocal t(9;22) ABL\/BCR fusion proteins: leukemogenic potential and effects on B cell commitment. PLoS One. 2009;4:e7661.","journal-title":"PLoS One"},{"key":"522_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27767-6","volume":"8","author":"M Tamai","year":"2018","unstructured":"Tamai M, Inukai T, Kojika S, Abe M, Kagami K, Harama D, et al. T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR\/Cas9 system. Sci Rep. 2018;8:9966.","journal-title":"Sci Rep."},{"key":"522_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"522_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2879-1","volume":"20","author":"F Marini","year":"2019","unstructured":"Marini F, Binder H. pcaExplorer: an R\/Bioconductor package for interacting with RNA-seq principal components. BMC Bioinforma. 2019;20:331.","journal-title":"BMC Bioinforma"},{"key":"522_CR38","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139.","journal-title":"Bioinformatics"},{"key":"522_CR39","unstructured":"Blighe KR, S; Lewis M. EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling 2020."},{"key":"522_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"522_CR41","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"522_CR42","doi-asserted-by":"publisher","first-page":"30907","DOI":"10.1074\/jbc.M605902200","volume":"281","author":"MA Meyn 3rd","year":"2006","unstructured":"Meyn MA 3rd, Wilson MB, Abdi FA, Fahey N, Schiavone AP, Wu J, et al. Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity. J Biol Chem. 2006;281:30907\u201316.","journal-title":"J Biol Chem"},{"key":"522_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MOH.0b013e328302f711","volume":"15","author":"JA Nickoloff","year":"2008","unstructured":"Nickoloff JA, De Haro LP, Wray J, Hromas R. Mechanisms of leukemia translocations. Curr Opin Hematol. 2008;15:338\u201345.","journal-title":"Curr Opin Hematol"},{"key":"522_CR44","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/35015097","volume":"405","author":"C Richardson","year":"2000","unstructured":"Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature. 2000;405:697\u2013700.","journal-title":"Nature"},{"key":"522_CR45","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1101\/gr.147314.112","volume":"23","author":"M Piganeau","year":"2013","unstructured":"Piganeau M, Ghezraoui H, De Cian A, Guittat L, Tomishima M, Perrouault L, et al. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res. 2013;23:1182\u201393.","journal-title":"Genome Res"},{"key":"522_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4964","volume":"5","author":"R Torres","year":"2014","unstructured":"Torres R, Martin MC, Garcia A, Cigudosa JC, Ramirez JC, Rodriguez-Perales S. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat Commun. 2014;5:3964.","journal-title":"Nat Commun"},{"key":"522_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/B978-0-12-801185-0.00012-X","volume":"546","author":"B Renouf","year":"2014","unstructured":"Renouf B, Piganeau M, Ghezraoui H, Jasin M, Brunet E. Creating cancer translocations in human cells using Cas9 DSBs and nCas9 paired nicks. Methods Enzymol. 2014;546:251\u201371.","journal-title":"Methods Enzymol"},{"key":"522_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.molcel.2014.08.002","volume":"55","author":"H Ghezraoui","year":"2014","unstructured":"Ghezraoui H, Piganeau M, Renouf B, Renaud JB, Sallmyr A, Ruis B, et al. Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell. 2014;55:829\u201342.","journal-title":"Mol Cell"},{"key":"522_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4728","volume":"5","author":"PS Choi","year":"2014","unstructured":"Choi PS, Meyerson M. Targeted genomic rearrangements using CRISPR\/Cas technology. Nat Commun. 2014;5:3728.","journal-title":"Nat Commun"},{"key":"522_CR50","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.1038\/s41388-019-0937-9","volume":"38","author":"KA Secker","year":"2019","unstructured":"Secker KA, Keppeler H, Duerr-Stoerzer S, Schmid H, Schneidawind D, Hentrich T, et al. Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR\/Cas9. Oncogene. 2019;38:7181\u201395.","journal-title":"Oncogene"},{"key":"522_CR51","doi-asserted-by":"crossref","unstructured":"Secker KA, Bruns L, Keppeler H, Jeong J, Hentrich T, Schulze-Hentrich JM, et al. Only hematopoietic stem and progenitor cells from cord blood are susceptible to malignant transformation by MLL-AF4 translocations. Cancers (Basel) 2020;12:1487.","DOI":"10.3390\/cancers12061487"},{"key":"522_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27270-z","volume":"12","author":"S Rice","year":"2021","unstructured":"Rice S, Jackson T, Crump NT, Fordham N, Elliott N, O\u2019Byrne S, et al. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program. Nat Commun. 2021;12:6905.","journal-title":"Nat Commun"},{"key":"522_CR53","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1182\/bloodadvances.2017013748","volume":"2","author":"C Schneidawind","year":"2018","unstructured":"Schneidawind C, Jeong J, Schneidawind D, Kim IS, Duque-Afonso J, Wong SHK, et al. MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing. Blood Adv. 2018;2:832\u201345.","journal-title":"Blood Adv"},{"key":"522_CR54","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1182\/bloodadvances.2019000450","volume":"3","author":"J Jeong","year":"2019","unstructured":"Jeong J, Jager A, Domizi P, Pavel-Dinu M, Gojenola L, Iwasaki M, et al. High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells. Blood Adv. 2019;3:2825\u201335.","journal-title":"Blood Adv"},{"key":"522_CR55","doi-asserted-by":"crossref","unstructured":"Sarrou E, Richmond L, Carmody RJ, Gibson B, Keeshan K CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis. Int J Mol Sci. 2020;21:4266.","DOI":"10.3390\/ijms21124266"},{"key":"522_CR56","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3324\/haematol.2017.164046","volume":"102","author":"J Reimer","year":"2017","unstructured":"Reimer J, Knoss S, Labuhn M, Charpentier EM, Gohring G, Schlegelberger B, et al. CRISPR-Cas9-induced t(11;19)\/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo. Haematologica. 2017;102:1558\u201366.","journal-title":"Haematologica"},{"key":"522_CR57","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1182\/blood.V89.12.4537","volume":"89","author":"S Kozubek","year":"1997","unstructured":"Kozubek S, Lukasova E, Ryznar L, Kozubek M, Liskova A, Govorun RD, et al. Distribution of ABL and BCR genes in cell nuclei of normal and irradiated lymphocytes. Blood. 1997;89:4537\u201345.","journal-title":"Blood"},{"key":"522_CR58","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/blood.V93.4.1197","volume":"93","author":"H Neves","year":"1999","unstructured":"Neves H, Ramos C, da Silva MG, Parreira A, Parreira L. The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood. 1999;93:1197\u2013207.","journal-title":"Blood"},{"key":"522_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1182\/blood.V81.1.158.158","volume":"81","author":"JV Melo","year":"1993","unstructured":"Melo JV, Gordon DE, Cross NC, Goldman JM. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood. 1993;81:158\u201365.","journal-title":"Blood"},{"key":"522_CR60","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2018.04.016","volume":"70","author":"EK Brinkman","year":"2018","unstructured":"Brinkman EK, Chen T, de Haas M, Holland HA, Akhtar W, van Steensel B. Kinetics and fidelity of the repair of Cas9-induced double-strand DNA breaks. Mol Cell. 2018;70:801\u201313.e806.","journal-title":"Mol Cell"},{"key":"522_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04867-5","volume":"9","author":"R Bhargava","year":"2018","unstructured":"Bhargava R, Sandhu M, Muk S, Lee G, Vaidehi N, Stark JM. C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains. Nat Commun. 2018;9:2484.","journal-title":"Nat Commun"},{"key":"522_CR62","first-page":"1724","volume":"10","author":"DA Frank","year":"1996","unstructured":"Frank DA, Varticovski L. BCR\/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia. 1996;10:1724\u201330.","journal-title":"Leukemia"},{"key":"522_CR63","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1074\/jbc.274.22.15575","volume":"274","author":"T Yamaguchi","year":"1999","unstructured":"Yamaguchi T, Mukasa T, Uchida E, Kanayasu-Toyoda T, Hayakawa T. The role of STAT3 in granulocyte colony-stimulating factor-induced enhancement of neutrophilic differentiation of Me2SO-treated HL-60 cells. GM-CSF inhibits the nuclear translocation of tyrosine-phosphorylated STAT3. J Biol Chem. 1999;274:15575\u201381.","journal-title":"J Biol Chem"},{"key":"522_CR64","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","volume":"96","author":"F Gesbert","year":"2000","unstructured":"Gesbert F, Griffin JD. Bcr\/Abl activates transcription of the Bcl-X gene through STAT5. Blood. 2000;96:2269\u201376.","journal-title":"Blood"},{"key":"522_CR65","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood-2002-06-1890","volume":"102","author":"S Faderl","year":"2003","unstructured":"Faderl S, Harris D, Van Q, Kantarjian HM, Talpaz M, Estrov Z. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood. 2003;102:630\u20137.","journal-title":"Blood"},{"key":"522_CR66","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jare.2020.04.016","volume":"24","author":"SQ Li","year":"2020","unstructured":"Li SQ, Liu J, Zhang J, Wang XL, Chen D, Wang Y, et al. Transcriptome profiling reveals the high incidence of hnRNPA1 exon 8 inclusion in chronic myeloid leukemia. J Adv Res. 2020;24:301\u201310.","journal-title":"J Adv Res"},{"key":"522_CR67","doi-asserted-by":"publisher","first-page":"35604","DOI":"10.1074\/jbc.M401851200","volume":"279","author":"S Ray","year":"2004","unstructured":"Ray S, Lu Y, Kaufmann SH, Gustafson WC, Karp JE, Boldogh I, et al. Genomic mechanisms of p210BCR-ABL signaling: induction of heat shock protein 70 through the GATA response element confers resistance to paclitaxel-induced apoptosis. J Biol Chem. 2004;279:35604\u201315.","journal-title":"J Biol Chem"},{"key":"522_CR68","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0301-472X(02)00808-1","volume":"30","author":"T Nosaka","year":"2002","unstructured":"Nosaka T, Kitamura T. Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation. Exp Hematol. 2002;30:697\u2013702.","journal-title":"Exp Hematol"},{"key":"522_CR69","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.3139re6","volume":"3","author":"J Colicelli","year":"2010","unstructured":"Colicelli J. ABL tyrosine kinases: evolution of function, regulation, and specificity. Sci Signal. 2010;3:re6.","journal-title":"Sci Signal"},{"key":"522_CR70","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.stem.2015.08.008","volume":"17","author":"M Iwasaki","year":"2015","unstructured":"Iwasaki M, Liedtke M, Gentles AJ, Cleary ML. CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-rearranged acute myeloid leukemia. Cell Stem Cell. 2015;17:412\u201321.","journal-title":"Cell Stem Cell"},{"key":"522_CR71","doi-asserted-by":"crossref","unstructured":"Cui L, Moraga I, Lerbs T, Van Neste C, Wilmes S, Tsutsumi N, et al. Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors. Proc Natl Acad Sci USA. 2021;118:e2017849118.","DOI":"10.1073\/pnas.2017849118"},{"key":"522_CR72","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.1065173","volume":"295","author":"L Di Croce","year":"2002","unstructured":"Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science. 2002;295:1079\u201382.","journal-title":"Science"},{"key":"522_CR73","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1182\/blood-2006-08-041202","volume":"109","author":"G Jin","year":"2007","unstructured":"Jin G, Yamazaki Y, Takuwa M, Takahara T, Kaneko K, Kuwata T, et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood. 2007;109:3998\u20134005.","journal-title":"Blood"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-022-00522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-022-00522-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-022-00522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T19:03:01Z","timestamp":1673895781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-022-00522-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1038\/s41417-022-00522-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1437317\/v1","asserted-by":"object"}]},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}